What is the Share Price of Emmessar Biotech Nutrition Ltd?

Emmessar Biotech Nutrition Ltd share price is ₹33.99 As on 09 May, 2025|09:53

Home
>
Stocks
>
Emmessar Biotech Nutrition Ltd

Emmessar Biotech Nutrition Ltd Share Price

Q: What is the Market Cap of Emmessar Biotech Nutrition Ltd?

The Market Cap of Emmessar Biotech Nutrition Ltd is ₹16.1 As on 09 May, 2025|09:53

Q: What is PE Ratio of Emmessar Biotech Nutrition Ltd?

The P/E ratio of Emmessar Biotech Nutrition Ltd is 50.4 As on 09 May, 2025|09:53

Q: What is PB Ratio of Emmessar Biotech Nutrition Ltd?

The PB ratio of Emmessar Biotech Nutrition Ltd is 2.21 As on 09 May, 2025|09:53

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 4

Cons 6

Emmessar Biotech Nutrition Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 33.99 up by 5.40%. The total volume of shares on NSE and BSE combined was 11 shares. Its total combined turnover was Rs 0.00 crores.

Emmessar Biotech Nutrition Ltd Medium and Long Term Market Action

The stock price of Emmessar Biotech Nutrition Ltd is down by 0% over the last one month. Don't forget to check the full stock price history in the table below.

Emmessar Biotech Nutrition Ltd Fundamentals

Market Cap (Cr): 16.1
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Emmessar Biotech Nutrition Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Emmessar Biotech Nutrition Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Emmessar Biotech Nutrition Ltd

Data not available.

Emmessar Biotech Nutrition Ltd FAQ's

What is Share Price of Emmessar Biotech Nutrition Ltd?

What is the Market Cap of Emmessar Biotech Nutrition Ltd?

What is PE Ratio of Emmessar Biotech Nutrition Ltd?

What is PB Ratio of Emmessar Biotech Nutrition Ltd?

What is the CAGR of Emmessar Biotech Nutrition Ltd?

How to Buy Emmessar Biotech Nutrition Ltd Share?

Can I buy Emmessar Biotech Nutrition Ltd from Samco?

How do I buy Emmessar Biotech Nutrition Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 70.33% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.00. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
Above Average Growth Rate
The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Negative operating earnings and interest coverage
The company has a negative operating earnings and a negative Interest coverage ratio of -Infinity times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.43. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 79.87 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(09/05/2025)

101

Margin of Safety Index: High

0% People are bullish about Emmessar Biotech Nutrition Ltd

0 % People are bearish about Emmessar Biotech Nutrition Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %